| Humulus lupus extract rich in xanthohumol improves the clinical course in critically ill COVID-19 patients 2023 · Group Xn · Adults aged 22–83 with severe COVID-19 and acute respiratory failure admitted to the ICU | 4.5 mg/kg | 7 days | 25 |
| Matured hop extract reduces body fat in healthy overweight humans: a randomized, double-blind, placebo-controlled parallel group study 2016 · Active group · Men and women aged 20 to under 65 years with BMI 25 to under 30 kg/m² | 35 mg | 12 weeks | 100 |
| The relationship between the effect of matured hop extract and physical activity on reducing body fat: re-analysis of data from a randomized, double-blind, placebo-controlled parallel group study 2018 · active group · Men and women aged 20–65 years with BMI 25–30 kg/m² | 35 mg | 12 weeks | 91 |
| Supplementation with Matured Hop Bitter Acids Improves Cognitive Performance and Mood State in Healthy Older Adults with Subjective Cognitive Decline 2020 · MHBA group · Adults aged 45–69 years with subjective cognitive decline | 35 mg | 12 weeks | 49 |
| A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts 2010 · active treatment (hop extract) · Menopausal women; age range and condition details beyond menopausal discomforts not reported | 100 mcg | 8 weeks | 36 |
| Effects of a hops (Humulus lupulus L.) dry extract supplement on self-reported depression, anxiety and stress levels in apparently healthy young adults: a randomized, placebo-controlled, double-blind, crossover pilot study 2017 · Melcalin hops · Apparently healthy young adults aged about 25 years reporting at least mild depression, anxiety and stress symptoms; 31 females and 5 males completed the study | 200 mg | 4 weeks | 36 |
| New Zealand Bitter Hops Extract Reduces Hunger During a 24 h Water Only Fast 2019 · high dose (HD) · Healthy lean men; participants were 18–40 years old, with BMI 20–24.9 kg/m². | 500 mg | 1 day | 30 |
| New Zealand Bitter Hops Extract Reduces Hunger During a 24 h Water Only Fast 2019 · low dose (LD) · Healthy lean men; participants were 18–40 years old, with BMI 20–24.9 kg/m². | 200 mg | 1 day | 30 |
| An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial 2022 · Quick-release capsules (gastric) · Healthy-weight men | 500 mg | 1 day | 19 |
| An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial 2022 · Delayed-release capsules (duodenal) · Healthy-weight men | 500 mg | 1 day | 19 |
| A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts 2006 · 100 microg 8-PN hop extract group · Menopausal women; age range and menopausal condition details not reported | 100 mcg | 12 weeks | — |
| A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts 2006 · 250 microg 8-PN hop extract group · Menopausal women; age range and menopausal condition details not reported | 250 mcg | 12 weeks | — |
| Hop polyphenols suppress production of water-insoluble glucan by Streptococcus mutans and dental plaque growth in vivo 2008 · High-dosage group · Healthy subjects; age and sex not reported | 140 mg | 3 days | — |
| Hop polyphenols suppress production of water-insoluble glucan by Streptococcus mutans and dental plaque growth in vivo 2008 · Low-dosage group · Healthy subjects; age and sex not reported | 49 mg | 3 days | — |
| Effects of Hop Bitter Acids, Bitter Components in Beer, on Cognition in Healthy Adults: A Randomized Controlled Trial 2020 · MHBAs-treated group · Healthy adults aged 45–64 years with self-awareness of cognitive decline | 35 mg | 12 weeks | — |
| Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial 2005 · valerian-hops combination · Adults with mild insomnia; mean age 44.3 years; 110 women and 74 men across the study | 41.9 mg | 4 weeks | 59 |
| Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial 2013 · NSF-3 group · Adults of either sex diagnosed with primary insomnia | 30 mg | 2 weeks | 39 |
| Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms 2008 · verum · Poor sleepers identified by the validated sleep questionnaire SF-B; age and sex not reported | 2 mL | 1 day | 20 |
| Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial 2025 · Ze 91019 · Healthy men and women aged 18–65 with occasional sleep problems and subjective cognitive difficulties, without diagnosed insomnia | 120 mg | 3 weeks | 18 |
| Rice Protein Matrix Enhances Circulating Levels of Xanthohumol Following Acute Oral Intake of Spent Hops in Humans 2018 · spent hops-rice protein matrix preparation · Healthy participants; age and sex not specified | 12.4 mg | 1 day | 6 |
| Rice Protein Matrix Enhances Circulating Levels of Xanthohumol Following Acute Oral Intake of Spent Hops in Humans 2018 · control spent hops preparation · Healthy participants; age and sex not specified | 12.4 mg | 1 day | 6 |
| Impact of xanthohumol (a prenylated flavonoid from hops) on DNA stability and other health-related biochemical parameters: Results of human intervention trials 2016 · XN drink · Participants; age, sex, and health condition not reported | 12 mg | — | 22 |
| The Oral Bioavailability of 8-Prenylnaringenin from Hops (Humulus Lupulus L.) in Healthy Women and Men is Significantly Higher than that of its Positional Isomer 6-Prenylnaringenin in a Randomized Crossover Trial 2018 · 6-PN · Healthy women and men; ages not stated | 500 mg | 1 day | 16 |
| The Oral Bioavailability of 8-Prenylnaringenin from Hops (Humulus Lupulus L.) in Healthy Women and Men is Significantly Higher than that of its Positional Isomer 6-Prenylnaringenin in a Randomized Crossover Trial 2018 · 8-PN · Healthy women and men; ages not stated | 500 mg | 1 day | 16 |
| A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women 2022 · XN-rich hop extract · Healthy, normal-weight women; age not stated | 125 mcg | 1 day | 9 |
| Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial 2021 · xanthohumol · Adults aged 21–50 years who were healthy, without stated chronic disease | 24 mg | 8 weeks | 16 |
| Nutritional supplementation of hop rho iso-alpha acids, berberine, vitamin D₃, and vitamin K₁ produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome 2011 · intervention arm · Postmenopausal women with metabolic syndrome | 400 mg | 14 weeks | 25 |
| Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial 2010 · treatment arm · Healthy postmenopausal women | 400 mg | 14 weeks | 16 |